Teva Part of Consortium Looking to Participate in Purdue Pharma's Bankruptcy, Report Says | Ctech
Johnson & Johnson, Teva, others face federal criminal probe into opioid sales: WSJ | Fierce Pharma
Mylan's Leverage to Resist Teva Deal Reveals Shift in Rules - WSJ
How Teva Beat the Big Pharma Curse to Win 2018 | Barron's
Teva Pharmaceutical Industries Ltd ADR (TEVA-N) Quote - The Globe and Mail
Pharmakonzern Teva: König der Kopisten - manager magazin
Teva Pharmaceutical Is in Recovery - WSJ
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says | Ctech
Israeli drug manufacturer Teva at center of anti-trust lawsuit brought by 44 states - Jewish Telegraphic Agency
Teva Settles Foreign Corruption Probe for $519 Million - WSJ
Intas To Buy Teva's UK, Ireland Assets For 603 Million Pounds
Oklahoma, USA: Opioid-Krise: Ratiopharm-Mutter Teva zahlt 85 Millionen US-Dollar
Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Teva May Need to Pay Up to Lure a CEO Able to Reverse Its Fortunes - WSJ
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Now Comes the Hard Part at Teva - WSJ
Teva found liable for fueling opioid addiction in New York | Mint
Teva Investors Get Headache Relief - WSJ
Teva in talks to buy Allergan big generic-drug unit: WSJ | Reuters.com
Teva Nears Deal For Allergan's Generic Drugs Unit | Mint
Teva Pharmaceutical's Sales Slump 18% - WSJ
Legislators Seek US FDA Input On Teva Proposed Opioid Settlement :: Pink Sheet
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
FDA Rejects Teva's Application For Huntington's Drug - WSJ
利回りのない世界、希望的観測抱く投資家 | WSJ PickUp | ダイヤモンド・オンライン
Israel stocks at record; banks, Teva in focus - MarketWatch
